Treatment of Multidrug-Resistant Tuberculosis during Pregnancy: A Report of 7 Cases

Shin, Sonya; Guerra, Dalia; Rich, Michael; Seung, Kwonjune J.; Mukherjee, Joia; Joseph, Keith; Hurtado, Rocio; Alcantara, Felix; Bayona, Jamie; Bonilla, Cesar; Farmer, Paul; Furin, Jennifer
April 2003
Clinical Infectious Diseases;4/15/2003, Vol. 36 Issue 8, p996
Academic Journal
Describes seven patients who were treated for multidrug-resistant tuberculosis (MDR-TB) during pregnancy. Extensive parenchymal damage and high-grade resistance to antituberculous drugs; Successful treatment of MDR-TB during pregnancy.


Related Articles

  • Multidrug-resistant tuberculosis. Zager, Ellen M.; McNerney, Ruth // BMC Infectious Diseases;2008, Vol. 8 Issue 1, Special section p1 

    Background: With almost 9 million new cases each year, tuberculosis remains one of the most feared diseases on the planet. Led by the STOP-TB Partnership and WHO, recent efforts to combat the disease have made considerable progress in a number of countries. However, the emergence of mutated...

  • Bedaquiline: A new drug approved for treatment of multidrug-resistant tuberculosis. Deoghare, Shashank // Indian Journal of Pharmacology;Sep-Oct2013, Vol. 45 Issue 5, p536 

    A letter to the editor is presented about bedaquiline, a new drug for multidrug-resistant tuberculosis (MDR-TB).

  • Levofloxacin.  // Reactions Weekly;Jul2014, Vol. 1510 Issue 1, p28 

    The author argues on the paper, "Management of latent tuberculosis infection in child contacts of multidrug-resistant tuberculosis," which focuses on a retrospective review of 13 boys and 13 girls who undergo antitubercular treatment after multidrug resistant tuberculosis exposure.

  • Turning the tables on TB. PAYNE, RICHARD // Chemistry in Australia;Oct2013, p16 

    The article offers information on the treatment of tuberculosis (TB) using drug comprising a combination therapy of four drugs (rifampicin, isoniazid, ethambutol and pyrazinamide) for six months, alongside observation of the treatment course by a medical professional. However, poor adherence to...

  • In vitro effect of fluoroquinolones against Mycobacterium tuberculosis isolates from Agra & Kanpur region of north India. Singh, Mradula; Chauhan, D. S.; Gupta, Pushpa; Das, R.; Srivastava, R. K.; Upadhyay, Prashant; Singh, Pushpendra; Srivastava, K.; Faujdar, Jaya; Jaudaun, G. P. S.; Yadav, V. S.; Sharma, V. D.; Venkatesan, K.; Sachan, S.; Sachan, P.; Katoch, K.; Katoch, V. M. // Indian Journal of Medical Research;May2009, Vol. 129 Issue 5, p542 

    Background & objectives: Fluoroquinolones (FQs) are important drugs used for treatment of drug resistant tuberculosis and are also now being considered as first line drugs to shorten the duration of treatment of tuberculosis (TB). In order to find out useful FQs for treatment of tuberculosis,...

  • Prevalence of multidrug-resistant tuberculosis among Category II pulmonary tuberculosis patients. Sharma, Surendra K.; Kumar, Sanjeev; Saha, P. K.; George, Ninoo; Arora, S. K.; Gupta, Deepak; Singh, Urvashi; Hanif, M.; Vashisht, R. P. // Indian Journal of Medical Research;Mar2011, Vol. 133 Issue 3, p312 

    Background & objectives: Multidrug-resistant tuberculosis (MDR-TB) has emerged as a significant global health concern. The most important risk factor for the development of MDR-TB is previous antituberculosis therapy. Category II pulmonary TB includes those patients who had failed previous TB...

  • Multi Drug and Other Forms of Drug Resistant Tuberculosis Are Uncommon among Treatment Naïve Tuberculosis Patients in Tanzania. Nagu, Tumaini J.; Aboud, Said; Mwiru, Ramadhani; Matee, Mecky; Fawzi, Wafaie; Mugusi, Ferdinand // PLoS ONE;Apr2015, Vol. 10 Issue 4, p1 

    Background: Surveillance and effective management of drug resistance is important to sustaining tuberculosis (TB) control efforts. We aimed to determine resistance rates to first line anti tuberculosis drugs and to describe factors associated with the resistance to any of the first line anti...

  • MEDICINAL CHEMISTRY AND DEVELOPMENT OF ANTITUBERCULAR DRUGS. Kumar, Piyush; Rawat, Pinki; Singh, Pooja // International Journal of Pharmaceutical Sciences & Research;Jun2013, Vol. 4 Issue 6, p2080 

    Tuberculosis (TB) is an ancient disease that has caused inestimable suffering and claimed millions of lives over the centuries. Resistant strains of Mycobacterium tuberculosis have slowly emerged especially in developing countries due to the lack of health care organisation in order to provide...

  • Extensively drug-resistant tuberculosis: epidemiology and management. Matteelli, Alberto; Roggi, Alberto; Carvalho, Anna C. C. // Clinical Epidemiology;2014, Vol. 6, p111 

    The advent of antibiotics for the treatment of tuberculosis (TB) represented a major breakthrough in the fight against the disease. However, since its first use, antibiotic therapy has been associated with the emergence of resistance to drugs. The incorrect use of anti-TB drugs, either due to...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics